Počet záznamov: 1
myasthenia gravis
SYS d009157 LBL 00000cz--a2200000n--4500 005 20250606213914.5 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a C04.588.614.550.500 065 $a C04.730.856.490 065 $a C10.114.656 065 $a C10.574.781.588 065 $a C10.668.758.725 065 $a C20.111.258.500 066 $a 01 $c 03 089 $a 616.831.8-009.17 150 $a myasthenia gravis $x BL $x CF $x CI $x CL $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $2 slo 450 $w v $a Anti-MuSK Myasthenia Gravis $2 eng 450 $w v $a Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis $2 eng 450 $w v $a Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis $2 eng 450 $w v $a MuSK MG $2 eng 450 $w v $a MuSK Myasthenia Gravis $2 eng 450 $w v $a myasténia ťažká $2 slo 450 $w v $a slabosť svalová ťažká $2 slo 450 $w v $a myasténia gravis s anti-MuSK protilátkami $2 slo 450 $w v $a MuSK MG $2 slo 450 $w v $a MuSK myasténia gravis $2 slo 450 $w v $a MSRTK typ myasténie gravis $2 slo 450 $w v $a myasténia gravis so svalovo špecifickou receptorovou kinázou $2 slo 450 $w v $a myasténia gravis séronegatívna, s autoprotilátkami proti MuSK $2 slo 450 $w v $a SNMG s autoprotilátkami proti MuSK $2 slo 450 $w v $a myasténia gravis séronegatívna, bez autoprotilátok proti MuSK $2 slo 450 $w v $a SNMG bez autoprotilátok proti MuSK $2 slo 450 $w v $a myasténia gravis, generalizovaná $2 slo 450 $w v $a myasténia gravis, okulárna $2 slo 450 $w v $a myasténia gravis, očná $2 slo 550 $7 sllk_us_auth*d013952 $Y Thymus Hyperplasia $w p $a hyperplázia týmusu 550 $7 sllk_us_auth*d013952 $Y Thymus Hyperplasia $w b $a hyperplázia týmusu 550 $7 sllk_us_auth*d020294 $Y Myasthenic Syndromes, Congenital $w b $a syndrómy myastenické vrodené 680 9-
$i A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. $2 eng 680 $a "myasthenia" unqualified in foreign titles is more often MYASTHENIA GRAVIS than MUSCLE WEAKNESS but check text; congenital: consider MYASTHENIC SYNDROMES, CONGENITAL or specifics $2 eng 750 -2
$a Myasthenia Gravis $2 eng 980 $x M
Počet záznamov: 1